Moreno's Match-Worn Roma-Cagliari Shirt, Special Sponsor Telethon

关闭

Ended:Tuesday 16 January EST 2018 于 12:15

Winner: marquito

€500($535 USD)

慈善百分比

85%

错过了？

另一个独特的物品可能就在您身边！

联系我们

慈善百分比

85%

奖品

Win this red AS Roma home shirt, worn on the bench by the Mexican defender Hector Moreno for a match against Cagliari, valid for the 17th day of the 2017/18 Serie A Championship.

The game played on December 16, 2017 ended 1-0 in favor of Roma, thanks to the goal by Federizo Fazio in the 94th minute.

The Serie A football teams played once again to support research on the treatment of rare genetic diseases, this year for the 28th Telethon promoted by the foundation.

For the fifth year in a row, Roma wore the Telethon logo on their shirts, this year as part of the #presente campaign.

In the past, Roma wore the shirts with the Telethon logo in matches against various teams: in 2013 against Milan, in 2014 and 2015 against Genoa, and in 2016 against Juventus.

Features:

Short-sleeve red shirt
Roma emblem applique on chest
Sponsored by Nike
Special Sponsor Telethon
Serie A TIM patch applique on right sleeve
Sublimation-printed internal label
Name and number in thin plastic applique
#15, size M

Matchday Authenticated: B164602772

通过拍卖方式购买独特的物品前还需要买家的仔细评估。我们邀请您在购买之前查看您所掌握的所有信息和资料，包括我们的退货政策。

原因

Since 1990, we have been investing in the best research to find cures for rare genetic diseases. Because these diseases are so rare, often times there is no research being done on them, never mind therapeutic options or a cure.

We want to change this state of affairs because we believe that every person is worth fighting for.

We focus on transforming the results of excellent scientific research projects, selected and supported over time, into accessible treatments.

Finding a cure is not the final destination but a new starting point. We have to make every possible effort to guarantee that successful forms of treatment discovered through the research funded by Telethon are then made available to all patients.

For this reason we also work to develop partnerships with public health care institutions and pharmaceutical companies, so that the results of our research will translate to treatment and medicine accessible to all patients worldwide.

网站